Ftse Mib
36.248,97
-0,05%
DAX
21.013,74
0,56%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
105.984,94
2,80%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ocuphire Pharma Inc (OCUP) Ocuphire Pharma Inc (OCUP) Notizie

Ocuphire Pharma Inc

OCUP
1,17
0,00 (0,00%)
17 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/1/202515:10EDGAR2Form 8-K - Current report
13/1/202523:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/1/202523:10EDGAR2Form 8-K/A - Current report: [Amend]
06/1/202522:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202415:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202414:23EDGAR2Form 8-K - Current report
07/11/202412:08EDGAR2Form D - Notice of Exempt Offering of Securities
05/11/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202423:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/10/202422:26EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
29/10/202422:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/10/202418:00PRNUSThe RD Fund Announces Ocuphire Pharma's Acquisition of Opus..
24/10/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202423:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/10/202423:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/10/202423:09EDGAR2Form 8-K - Current report
13/8/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202414:14EDGAR2Form 8-K - Current report
13/6/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202422:06EDGAR2Form 8-K - Current report
24/5/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202422:30EDGAR2Form 8-K - Current report
10/5/202414:12EDGAR2Form 8-K - Current report
08/3/202423:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202414:21EDGAR2Form 8-K - Current report
16/2/202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202422:03EDGAR2Form 8-K - Current report
15/2/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/2/202400:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/1/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 1,17

La tua Cronologia

NASDAQ
OCUP
Ocuphire Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network